Clinical trial
A Randomized Study of Cotrimoxazole Prophylaxis and Longer Breastfeeding Duration to Improve Survival Among HIV-Exposed Infants in Botswana
NCT01229761 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Study of Cotrimoxazole Prophylaxis and Longer Breastfeeding Duration to Improve Survival Among HIV-Exposed Infants in Botswana
- Lead sponsor
- Harvard School of Public Health (HSPH)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2011
- Completion date
- October 31, 2018
- Enrollment
- 3,724 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.